COMP <GO>
DGX vs CNC // EV/EBITDA & P/E VALUATION
Quest Diagnostics Incorporated (NYSE) VS. Centene Corporation (NYSE) • 15-METRIC TALLY: DGX 10
— CNC 3
■ METRIC PARITY
LAST: $251.82 (-0.43%) • MKT CAP: $27.83B
valuation
16.3x
LAST: $68.45 (-0.25%) • MKT CAP: $33.97B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DGX VS. CNC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DGX | CNC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.20% | 8.10% | +25.10 | DGX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.30% | -31.00% | +41.30 | DGX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 16.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.88% | 12.72% | -7.84 | CNC | /fcf-yield <GO> |
| Operating Margin | 14.10% | -4.40% | +18.50 | DGX | /operating-margins <GO> |
| Net Profit Margin | 9.00% | -3.80% | +12.80 | DGX | /net-margins <GO> |
| Revenue Growth (YoY) | 11.80% | 20.00% | -8.20 | CNC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.27% | 0.00% | +1.27 | DGX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.01 | 2.52 | +1.49 | DGX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | DGX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 69.4 | 53.9 | +15.50 | DGX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.94 | +0.07 | DGX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.1x | 36.0x | -9.90 | DGX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.83B | $33.97B | -$6.15B | CNC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DGX REV | CNC REV | DGX GROSS % | CNC GROSS % | DGX FCF | CNC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.04B | $174.58B | 33.2% | 8.1% | $1.36B | $4.32B |
| FY 2024 | $9.87B | $145.50B | 32.9% | 11.7% | $909.0M | -$490.0M |
| FY 2023 | $9.25B | $140.09B | — | — | $855.7M | $1.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DGX // BETA 1.01
CNC // BETA 0.94